Could a serpin antibody help to treat type 1 diabetes?

Dr Jan Czyzyk explores the biomolecules serpins, and how serpin activity can affect the inflammation and tissue regeneration of cells in the pancreas. Their research opens the possibility for anti-serpin activity to be used as both a biomarker and an active mechanism of protection for individuals with type 1 diabetes.

Read more in Research Outreach

Read the original article: https://www.doi.org/10.1126/scitranslmed.abf1587